GeneDx Holdings Corp’s recent filing unveils that its Stockholder ICAHN SCHOOL OF MEDICINE AT MO acquired Company’s shares for reported $25.26 million on Apr 14 ’25. In the deal valued at $101.04 per share,250,000 shares were bought.
Then, Feeley Kevin sold 15,516 shares, generating $1,430,334 in total proceeds. Upon selling the shares at $92.18, the CHIEF FINANCIAL OFFICER now owns 1,726 shares.
Before that, Stueland Katherine sold 46,594 shares. GeneDx Holdings Corp shares valued at $4,175,817 were divested by the Chief Executive Officer at a price of $89.62 per share. As a result of the transaction, Stueland Katherine now holds 1,720 shares, worth roughly $0.16 million.
Wells Fargo initiated its GeneDx Holdings Corp [WGS] rating to an Equal weight in a research note published on August 28, 2024; the price target was $34. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating.
Price Performance Review of WGS
On Thursday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock fall -2.86% to $95.47. Over the last five days, the stock has gained 3.08%. GeneDx Holdings Corp shares have risen nearly 24.21% since the year began. Nevertheless, the stocks have risen 893.44% over the past one year. While a 52-week high of $115.60 was reached on 02/19/25, a 52-week low of $8.63 was recorded on 02/07/25. SMA at 50 days reached $91.84, while 200 days put it at $64.96.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 93.00, which if violated will result in even more drops to 90.53. On the upside, there is a resistance level at 97.86. A further resistance level may holdings at 100.25. The Relative Strength Index (RSI) on the 14-day chart is 52.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.77, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 23.86%. Stochastics %K at 86.55% indicates the stock is a selling.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-03-31, growing by 0.24 million shares to a total of 2.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 2.52 million shares. There was a rise of 8.54%, which implies that there is a positive sentiment for the stock.
